Showing results (221-230 of 6,760) with videos related to

Sort By:
Pageof 676
Clinical Therapeutics|April 12, 2022
Efficacy and Safety of SID142 in Patients With Peripheral Arterial Disease: A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group, Phase III Clinical TrialHyungdon Kook, Cheol Woong Yu, Donghoon Choi, et al.
Clinical Therapeutics|April 12, 2022
A Phase I, Open-label, Randomized, Crossover Study of the Relative Bioavailability of Capsule and Granule Formulations of SelumetinibSarit Cohen-Rabbie, Alexandra Mattinson, Karen So, et al.
Clinical Therapeutics|February 6, 2022
Establishing PK Equivalence Between Adalimumab and ABP 501 in the Presence of Antidrug Antibodies Using Population PK ModelingSameer Doshi, Hui Wang, Vincent Chow
Clinical Therapeutics|April 1, 2022
Insomnia Treatment Preferences Among Primary Care PatientsElliottnell Perez, Emily K Donovan, Bruce D Rybarczyk, et al.
Clinical Therapeutics|January 1, 1986
Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasisI Willis, R C Cornell, N S Penneys, et al.
Clinical Therapeutics|January 1, 1986
Zopiclone: a new nonbenzodiazepine hypnotic used in general practiceT C Monchesky, B J Billings, R Phillips
Clinical Therapeutics|March 10, 2022
Greater Adherence and Persistence with Injectable Dulaglutide Compared with Injectable Semaglutide at 1-Year Follow-up: Data from US Clinical PracticeReema Mody, Janna Manjelievskaia, Elizabeth H Marchlewicz, et al.
Clinical Therapeutics|March 4, 2022
Burden of Illness and Treatment Patterns in Second-line Large B-cell LymphomaJulia Thornton Snider, Donna McMorrow, Xue Song, et al.
Clinical Therapeutics|September 23, 2021
Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 InfectionJin Yong Kim, Young Rock Jang, Jang Hee Hong, et al.
Clinical Therapeutics|April 17, 2019
An Analysis of Time to Improvement in Oxygenation in Japanese Preterm and Late Preterm or Term Neonates With Hypoxic Respiratory Failure and Pulmonary HypertensionWilliam D Rhine, Satoshi Suzuki, Jim L Potenziano, et al.
Pageof 676